GENERIC NAME | latanoprostene bunod ophthalmic solution, 0.024% |
INDICATION'S | Ophthalmo>Glaucoma |
STATUS |
Approved in: AR; BR; CA; HK; MX; TW & Ukraine Launched in: USA |
UPDATE | 2021. 04.16 |
COMPANY | This data is not available for free |
PATENT ASSIGNEE | This data is not available for free |
Want more information ? Interested in the hidden information ? Click here and do your request. |